Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada


BACKGROUND: Eplerenone has been demonstrated as being cost effective for the treatment of patients with systolic heart failure (HF) and mild symptoms in several jurisdictions; however, its cost effectiveness is unknown in the context of Alberta, Canada.

Publication Type: Journal Articles

Year of Publication: 2016

Topics: Health Economics / Healthcare Costs, Therapy

Authors: Thanh Nguyen, Justin Ezekowitz, Dat Tran, Padma Kaul

ISSN: 1175-3277

ISSN (online): 1179-187X

Journal Title: American Journal of Cardiovascular Drugs